Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
- PMID: 28652786
- PMCID: PMC5476602
- DOI: 10.2147/IDR.S135935
Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
Abstract
Background: Various studies have reported that the emergence of drug-resistant tuberculosis poses a significant threat to tuberculosis-control programs worldwide. Rifampicin resistance is a surrogate marker of multidrug-resistant tuberculosis, since it reveals the presence of greater than 90% isoniazid resistance. Evidence on rifampicin-resistant Mycobacterium tuberculosis is scarce in the literature.
Objective: To determine the prevalence of rifampicin-resistant M. tuberculosis among tuberculosis-presumptive cases at the University of Gondar Hospital.
Materials and methods: A retrospective study was conducted at the University of Gondar Hospital from January 2013 to August 2015. Data were collected from registration books using a data-extraction format after securing ethical approval and checking the completeness of necessary information. Data were double-entered and rechecked to ensure accuracy and analyzed using SPSS version 20. Results were summarized using descriptive statistics. Associations were assessed using Fisher's exact test, and P<0.05 was considered statistically significant.
Results: A total of 1,820 M. tuberculosis-presumptive patients were included in the study. The majority of the study participants were males (59.2%). The mean age of the participants was 36.6±15.8 years. The preponderant age-group was 24-30 years, with 477 (23.5%) patients. The overall prevalence of M. tuberculosis-confirmed cases was 448 (24.6%, 95% CI 0.23-0.27). Of the 448 M. tuberculosis-confirmed cases, 71 (15.8%, 95% CI 1.12-1.19) were resistant to rifampicin. Rifampicin-resistant M. tuberculosis was observed among HIV seropositives (14 [18.7%]), males (45[17.3%]), and previously treated tuberculosis patients (61 [16.5%]), although no significant association was found in this study.
Conclusion: The overall prevalence of M. tuberculosis and rifampicin resistance was found to be high in tuberculosis patients in this study. Therefore, early detection of drug-resistant M. tuberculosis should be strengthened for management of tuberculosis patients.
Keywords: University of Gondar Hospital; rifampicin-resistant; tuberculosis.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- World Health Organization . Global Tuberculosis Report 2016. Geneva: WHO; 2016.
-
- Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8:359–368. - PubMed
-
- World Health Organization Definitions and reporting framework for tuberculosis – 2013 revision. 2013. [Accessed May 23, 2017]. Available from: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/meeti....
-
- World Health Organization . Global Tuberculosis Report 2015. Geneva: WHO; 2015.
LinkOut - more resources
Full Text Sources
Other Literature Sources
